FDI Regulations in Indian Pharmaceutical Sector: A Game-changer?
In June 2016, the Indian government liberalized its FDI policy in the pharmaceuticals sector by allowing 74% FDI under automatic route in brownfield pharmaceutical investments (investment in an existing plant)....



